SCI Abstract

search
LMTK3 regulates breast cancer angiogenesis via a context-dependent mesenchymal-epithelial transition program
LMTK3 regulates breast cancer angiogenesis via a context-dependent mesenchymal-epithelial transition program
Angiogenesis constitutes a critical rate-limiting determinant of tumor progression in breast cancer (BC). Resistance to co...
Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy
Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy
CRISPR/Cas9 represents a transformative advancement in precision therapies, offering the promise of more effective and tar...
Therapeutic advances with KRASG12C inhibitors and combination strategies in non-small cell lung cancer brain metastases
Therapeutic advances with KRASG12C inhibitors and combination strategies in non-small cell lung cancer brain metastases
Non-small cell lung cancer (NSCLC) frequently metastasizes to the brain in approximately 20–40% of cases. Mutations ...
Correction: Targeted suppression of tumor growth by CREPT promoter-driven diphtheria toxin fragment A
State Key Laboratory of Membrane Biology, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijin...
MSCs delivering LIGHT prime immune response against CAFs to harness antigen loss variants
MSCs delivering LIGHT prime immune response against CAFs to harness antigen loss variants
The tumor niche promotes immune tolerance, enabling malignant cells to evade surveillance. Mesenchymal stem cells (MSCs) h...
Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway
Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway
Drug resistance exhibited by cancer cells remains one of the primary reasons for the failure of therapeutic approaches to ...
AAV for ovarian cancer gene therapy
AAV for ovarian cancer gene therapy
Recent advancements in ovarian cancer treatment, particularly with PARP inhibitors, have markedly enhanced the recurrence-...
UBE2N inhibition abrogates cancer chemoresistance and metastasis in lung adenocarcinoma
UBE2N inhibition abrogates cancer chemoresistance and metastasis in lung adenocarcinoma
Chemoresistance and metastasis remain significant challenges in cancer therapy, resulting in treatment failures for cancer...
The dual role of GPX4 in breast cancer: mechanisms of therapeutic resistance and potential for novel targeted therapies
The dual role of GPX4 in breast cancer: mechanisms of therapeutic resistance and potential for novel targeted therapies
Glutathione peroxidase 4 (GPX4) is a key intracellular antioxidant enzyme that maintains oxidative homeostasis by catalyzi...
Barriers and solutions for CAR-T therapy in solid tumors
Barriers and solutions for CAR-T therapy in solid tumors
Chimeric antigen receptor (CAR)-T cell therapy has emerged as a transformative approach for cancer treatment, particularly...
Enhancer hijacking drives FAM20C expression to promote papillary thyroid cancer progression
Enhancer hijacking drives FAM20C expression to promote papillary thyroid cancer progression
Papillary thyroid cancer (PTC) is the most common endocrine cancer, with a good prognosis in most cases. However, aggressi...
SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma
SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma
Alveolar type II epithelial (AT2) cells have the properties of stem cells, abnormal AT2 cells serve as one of the original...
Modification of the tumor microenvironment enhances immunity with plasmid gene therapy
Modification of the tumor microenvironment enhances immunity with plasmid gene therapy
Local intratumor delivery with electroporation of low levels of plasmids encoding molecules, induces an antitumor effect w...
Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p/FBXW7/HSF1 axis under hypoxic microenvironment
Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p/FBXW7/HSF1 axis under hypoxic microenvironment
Metastasis is the main cause of deaths in prostate cancer (PCa). However, the exact mechanisms underlying PCa metastasis a...
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Emerging role of RNA modification and long noncoding RNA interaction in cancer
RNA modification, especially N6-methyladenosine, 5-methylcytosine, and N7-methylguanosine methylation, participates in the...
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice
Recent pan-cancer genomic analyses have identified numerous oncogenic driver mutations that occur in a cell-type and tissu...
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma
Osteosarcoma is the most prevalent malignant bone tumour in children, adolescents and young adults. Despite a multitude of...
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
Dysregulated cellular proliferation represents a hallmark feature across all cancers. Aberrant activation of the cyclin-de...
SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma
SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma
Macrophages are heterogeneous cells that play multifaceted roles in cancer progression and metastasis. However, the phenot...
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer
Since trastuzumab was approved in 2012 for the first-line treatment of gastric cancer (GC), no significant advancement in ...
Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance
Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance
MSCs (mesenchymal stem cells), responsible for tissue repair, rarely undergo cell fusion with somatic cells. Here, we show...